EUVIMEDEUVIMED entdecken
Open Access

Laryngeal and Hypopharyngeal Malignancies: Where Do We Stand? A Retrospective Single-center Study

Petr Skopek, David Slouka, Bretislav Gal, Miroslav Tedla, Martin Pesta, Alena Skalova, Radek Kucera, Pavel Klail, Tomas Kostlivy

In Vivo · 2026

DOI: 10.21873/invivo.14204 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In Vivo, 2026. Verfasst von Petr Skopek und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology and Head and Neck Surgery, Faculty of Medicine in Pilsen, Charles University, University Hospital in Pilsen, Pilsen…. Hauptthemen laut MEDLINE: Squamous Cell Carcinoma of Head and Neck, Laryngeal Neoplasms, Head and Neck Neoplasms, Hypopharyngeal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Squamous cell carcinoma (SCC) of the larynx and hypopharynx shows subsite-specific patterns, with supraglottic tumors closely resembling hypopharyngeal SCC. This study aimed to analyze 10-year epidemiologic trends, management, and outcomes in a tertiary hospital, with emphasis on prognostic similarities between supraglottic and hypopharyngeal tumors. PATIENTS AND METHODS: A retrospective cohort of 454 patients with laryngeal or hypopharyngeal SCC (2012-2022) was evaluated. Demographic characteristics, TNM stage, treatment modality, and 5-year disease-specific survival (DSS) were analyzed. RESULTS: Hypopharyngeal SCC cases were predominantly advanced (T3-T4: 66.4%; N2-N3: 82.7%) and more often metastatic (29.8%), compared with laryngeal SCC (40.6%, 21.1%, and 5.4%, respectively; p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Squamous Cell Carcinoma of Head and NeckLaryngeal NeoplasmsHead and Neck NeoplasmsHypopharyngeal NeoplasmsRetrospective StudiesTertiary Care CentersPrognosisHumansMaleFemaleAdultMiddle AgedAgedAged, 80 and overNeoplasm StagingOrgan Sparing TreatmentsLaryngectomyPrevalenceIncidenceSurvival AnalysisPharyngectomyChemoradiotherapyAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, Adjuvant

Stichwörter der Autor:innen

PET/CTSquamous cell carcinomaTNM classificationdisease-specific survivalhypopharyngeal cancerlaryngeal cancerorgan preservation

Autor:innen und Institutionen

  • Department of Otorhinolaryngology and Head and Neck Surgery, Faculty of Medicine in Pilsen, Charles University, University Hospital in Pilsen, Pilsen, Czech Republic.
  • Department of Otorhinolaryngology and Head and Neck Surgery, Saint Anne's University Hospital and Faculty of Medicine, Masaryk University Brno, Brno, Czech Republic.
  • Department of Otorhinolaryngology and Head and Neck Surgery, Faculty of Medicine, Comenius University, University Hospital Bratislava, Bratislava, Slovakia.
  • Department of Biology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.
  • Department of Pathology, Faculty of Medicine in Pilsen, Charles University, University Hospital in Pilsen, Pilsen, Czech Republic.
  • Department of Pharmacology and Toxicology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.

Zitieren

APA

Skopek, P., Slouka, D., Gal, B., Tedla, M., Pesta, M., Skalova, A., Kucera, R., Klail, P., & Kostlivy, T. (2026). Laryngeal and Hypopharyngeal Malignancies: Where Do We Stand? A Retrospective Single-center Study. In Vivo. https://doi.org/10.21873/invivo.14204

Vancouver

Skopek P, Slouka D, Gal B, Tedla M, Pesta M, Skalova A, et al. Laryngeal and Hypopharyngeal Malignancies: Where Do We Stand? A Retrospective Single-center Study. In Vivo. 2026. doi:10.21873/invivo.14204

BibTeX
@article{Skopek2026,
  author = {Skopek, Petr and Slouka, David and Gal, Bretislav and Tedla, Miroslav and Pesta, Martin and Skalova, Alena and Kucera, Radek and Klail, Pavel and Kostlivy, Tomas},
  title = {Laryngeal and Hypopharyngeal Malignancies: Where Do We Stand? A Retrospective Single-center Study},
  journal = {In Vivo},
  year = {2026},
  doi = {10.21873/invivo.14204}
}
Kostenlos starten →